Home > Income Statement > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Revenue

    Back to Income Statement
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹3,454 Cr₹3,252 Cr₹3,278 Cr₹2,926 Cr₹3,224 Cr

What is the latest Revenue of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Revenue ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹3,454 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹3,454 Cr
Mar2023₹3,252 Cr
Mar2022₹3,278 Cr
Mar2021₹2,926 Cr
Mar2020₹3,224 Cr

How is Revenue of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2024 ₹3,454 Cr
6.21
Mar2023 ₹3,252 Cr
-0.80
Mar2022 ₹3,278 Cr
12.05
Mar2021 ₹2,926 Cr
-9.27
Mar2020 ₹3,224 Cr -

Compare Revenue of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹35,408.0 Cr -6.3% -9.4% 4.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,936.0 Cr -5.8% -3.2% 35.1% Stock Analytics
DIVIS LABORATORIES ₹152,157.0 Cr -2.8% -3.6% 44.7% Stock Analytics
CIPLA ₹116,200.0 Cr -3.9% -0.5% 13.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,325.0 Cr -1.2% 7.1% 17.8% Stock Analytics
ZYDUS LIFESCIENCES ₹98,037.4 Cr -2.7% -0.1% 40.9% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-6.3%

-9.4%

4.9%

SENSEX

-2.1%

-6.4%

7%


You may also like the below Video Courses